Circulating inhibitor bound elastase in patients with ankylosing spondylitis and rheumatoid arthritis and the influence of sulphasalazine treatment.
about
Measurement of plasma concentrations of polymorphonuclear elastase-alpha 1 proteinase inhibitor (elastase-alpha 1 antitrypsin) in patients with rheumatoid arthritis: interference by rheumatoid factorEnumeration of IgA producing cells by the enzyme linked immunospot (ELISPOT) technique to evaluate sulphasalazine effects in inflammatory arthritides.
P2860
Circulating inhibitor bound elastase in patients with ankylosing spondylitis and rheumatoid arthritis and the influence of sulphasalazine treatment.
description
1988 nî lūn-bûn
@nan
1988 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Circulating inhibitor bound el ...... e of sulphasalazine treatment.
@ast
Circulating inhibitor bound el ...... e of sulphasalazine treatment.
@en
Circulating inhibitor bound el ...... e of sulphasalazine treatment.
@nl
type
label
Circulating inhibitor bound el ...... e of sulphasalazine treatment.
@ast
Circulating inhibitor bound el ...... e of sulphasalazine treatment.
@en
Circulating inhibitor bound el ...... e of sulphasalazine treatment.
@nl
prefLabel
Circulating inhibitor bound el ...... e of sulphasalazine treatment.
@ast
Circulating inhibitor bound el ...... e of sulphasalazine treatment.
@en
Circulating inhibitor bound el ...... e of sulphasalazine treatment.
@nl
P2860
P356
P1476
Circulating inhibitor bound el ...... e of sulphasalazine treatment.
@en
P2093
Feltelius N
Hällgren R
P2860
P356
10.1136/ARD.47.1.10
P407
P577
1988-01-01T00:00:00Z